![]() |
市場調查報告書
商品編碼
2023898
獸醫處方寵物食品市場預測至2034年-全球分析(依產品類型、適應症、寵物品種、成分類型、配方類型、生命階段、通路和地區分類)Veterinary Diet Pet Food Market Forecasts to 2034 - Global Analysis By Product Type, Indication, Pet Type, Ingredient Type, Formulation Type, Life Stage, Distribution Channel, and By Geography |
||||||
根據 Stratistics MRC 的數據,預計到 2026 年,全球獸醫處方寵物食品市場規模將達到 188 億美元,並在預測期內以 8.4% 的複合年成長率成長,到 2034 年將達到 358 億美元。
獸醫處方寵物食品是指在獸醫的指導下,根據科學配方配製而成的營養產品,用於控制、治療或預防伴侶動物的特定疾病。與普通商業寵物食品不同,這些治療性食品採用精確的營養配比、調整後的礦物質含量和特殊成分,旨在支持器官功能、控制慢性疾病並改善整體健康。市場主要針對犬、貓及其他寵物,產品主要透過獸醫診所、寵物專賣店和線上管道銷售。
寵物肥胖和慢性疾病盛行率上升
寵物肥胖、糖尿病、腎臟疾病和胃腸道疾病發病率的上升直接推動了獸醫營養治療的需求。研究表明,超過一半的寵物犬貓臨床上超重或肥胖,這使它們更容易患上關節炎、泌尿系統疾病和代謝紊亂等繼發性疾病。隨著人們對這些健康風險的認知不斷提高,寵物飼主開始尋求獸醫的專業指導,獸醫也推薦治療性飲食作為第一線治療方案。寵物日益「擬人化」的觀念進一步加劇了這一趨勢。飼主將寵物視為家庭成員,並在營養管理方面投入大量資金,以預防疾病和治療慢性病。
它比普通寵物食品貴。
獸醫處方糧的高昂定價阻礙了其在價格敏感型飼主中的市場滲透,尤其是那些飼養多隻寵物或可支配收入有限的寵物主人。治療配方需要特殊的原料、嚴格的品管和獸醫的監督,所有這些因素加在一起,使得它們的價格是普通處方糧的兩到三倍。景氣衰退和通貨膨脹的壓力迫使一些飼主優先考慮價格因素而非治療性營養,這可能會影響疾病的治療效果。此外,獸醫處方糧的保險覆蓋範圍仍然不穩定,導致許多飼主必須承擔這些必要的營養干預措施的全部費用。
拓展電子商務和直接面對消費者的銷售管道
線上平台正為獸用治療食品開闢新的通路,提升患有慢性疾病的寵物飼主獲取治療食品的便利性。定期配送治療食品的訂閱模式降低了持續攝取的障礙,確保了治療的一致性。與遠端醫療的整合使獸醫能夠遠端開處方並監測飲食,從而將服務範圍擴展到農村和醫療資源匱乏的地區。提供獸醫處方產品的直接面對消費者(D2C)品牌正在湧現,它們繞過了透過動物醫院進行傳統分銷的管道,在保持醫療信譽的同時,提供具有競爭力的價格。這些數位化管道還能根據寵物健康數據提供個人化建議,提高治療的準確性和飼主的參與度。
監管機構正在加強對有關治療效果聲明的監管。
全球監管機構正加強對獸用治療食品標籤和健康益處聲明的審查,這給生產商帶來了合規風險。監管機構要求提供充分的科學證據來支持針對特定疾病的聲明,這需要耗費大量成本和時間的臨床試驗和同行評審研究。未經證實的行銷聲明可能導致產品召回、罰款和聲譽損害,而不同司法管轄區的法規差異也使全球產品上市更加複雜。小規模生產商在滿足這些證據要件面臨著特殊的挑戰,這可能會限制市場的多樣性和創新。這種法規環境設置了障礙,有利於擁有雄厚研發預算的大型成熟企業。
新冠疫情顯著加速了獸醫處方寵物食品的普及,這主要歸因於寵物飼養數量的激增和獸醫護理模式的改變。封鎖措施導致寵物領養數量空前成長,數百萬家庭迎來了寵物,擴大了目標市場。遠距辦公的興起提高了飼主對寵物健康的關注度,促使他們更早帶寵物就醫並開始嘗試營養療法。疫情期間遠距遠端醫療的普及鞏固了遠距處方治療性飲食的有效性,並建立了一條永續的數位化照護路徑。供應鏈中斷最初給生產帶來了挑戰,但獸醫處方食品的特殊性確保了其優先供應。整體而言,市場成長持續加速,人們對寵物健康照護的意識在後疫情時代也持續增強。
在預測期內,乾獸用治療食品領域預計將佔據最大的市場佔有率。
預計在預測期內,乾糧獸醫治療食品將佔據最大的市場佔有率,這主要得益於其便利性、成本效益和口腔衛生方面的益處。顆粒狀產品開封後保存期限長,易於儲存和計量,並能起到清潔牙齒的作用。製造商更容易控制營養密度,並在乾糧中配製耐熱的治療成分。寵物飼主喜歡乾糧,因為它比濕糧更經濟實惠,而且方便使用自動餵食器。此外,獸醫對乾糧的依從性更高,因為它有助於長期管理慢性疾病,無需每天烹飪。
在預測期內,「肥胖與體重管理」細分市場預計將呈現最高的複合年成長率。
在預測期內,「肥胖與體重管理」細分市場預計將呈現最高的成長率,這反映了寵物肥胖及其相關健康併發症在全球範圍內的普遍性。獸醫處方減重糧採用低熱量密度、高纖維和特定胺基酸配比,即使在熱量限制的情況下也能維持寵物的瘦肌肉量。人們越來越意識到肥胖會使寵物壽命縮短多達兩年,促使獸醫積極推薦體重管理干預措施。該細分市場受益於肥胖的高復發率,因為肥胖需要持續的營養支持而非短期治療。寵物飼主認可成功體重管理帶來的實際效果,這鼓勵他們繼續進行治療。
在整個預測期內,北美預計將保持最大的市場佔有率,這得益於其較高的寵物擁有率、先進的獸醫基礎設施以及在伴侶動物健康方面的強勁投入。該地區擁有全球最高的人均獸醫支出,寵物保險的普及也擴大了寵物獲得治療性食品的途徑。主要的獸醫處方糧生產商總部都設在北美,這確保了產品的快速創新,並透過成熟的動物醫院網路實現廣泛的分銷。消費者對寵物慢性病管理的認知已經較成熟,定期帶寵物去獸醫診所有助於診斷和製定飲食計畫。該地區「寵物擬人化」的趨勢最為顯著,從而推動了高階營養食品的普及。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於可支配收入的成長、快速的都市化以及中產階級家庭寵物擁有量的增加。隨著寵物飼養模式從戶外工作動物轉向室內伴侶動物,中國、日本和韓國等國家的獸醫服務正顯著成長。西方對寵物照護標準的影響,以及寵物肥胖和糖尿病盛行率的上升(反映了人類健康趨勢),正在推動對治療性營養食品的需求。政府支持獸醫基礎設施建設的措施以及國際製造商在該地區建立生產基地,進一步加速了市場在全部區域的滲透。
According to Stratistics MRC, the Global Veterinary Diet Pet Food Market is accounted for $18.8 billion in 2026 and is expected to reach $35.8 billion by 2034 growing at a CAGR of 8.4% during the forecast period. Veterinary diet pet food refers to scientifically formulated nutritional products designed to manage, treat, or prevent specific medical conditions in companion animals under veterinary supervision. Unlike standard commercial pet food, these therapeutic diets incorporate precise nutrient profiles, adjusted mineral levels, and specialized ingredients to support organ function, manage chronic diseases, and improve overall health outcomes. The market serves dogs, cats, and other pets, with products distributed primarily through veterinary clinics, specialty pet stores, and online channels.
Rising prevalence of pet obesity and chronic diseases
Increasing rates of pet obesity, diabetes, kidney disease, and gastrointestinal disorders are directly fueling demand for veterinary diet interventions. Studies indicate that over half of domestic dogs and cats are clinically overweight or obese, predisposing them to secondary conditions such as arthritis, urinary tract issues, and metabolic dysfunction. Pet owners, increasingly aware of these health risks, are seeking professional guidance from veterinarians who recommend therapeutic diets as first-line management tools. This trend is amplified by the growing humanization of pets, where owners treat animals as family members and invest significantly in preventive and chronic care nutrition.
Higher cost compared to standard pet food
The premium pricing of veterinary diet products restricts market penetration among price-sensitive pet owners, particularly those with multiple animals or limited disposable income. Therapeutic formulations require specialized ingredients, rigorous quality control, and veterinary oversight, all contributing to price points often two to three times higher than mainstream alternatives. Economic downturns and inflationary pressures force some owners to prioritize affordability over therapeutic nutrition, potentially compromising disease management outcomes. Additionally, insurance coverage for veterinary diets remains inconsistent, leaving many pet owners to bear the full financial burden of these medically necessary nutritional interventions.
Expansion of e-commerce and direct-to-consumer channels
Online platforms are creating new pathways for veterinary diet distribution, improving accessibility and convenience for pet owners managing chronic conditions. Subscription-based models offering regular delivery of therapeutic foods reduce adherence barriers and ensure consistent treatment. Telemedicine integration allows veterinarians to prescribe and monitor diet therapy remotely, expanding reach to rural and underserved areas. Direct-to-consumer brands are emerging with veterinarian-formulated products that bypass traditional clinic distribution, offering competitive pricing while maintaining medical credibility. These digital channels also enable personalized recommendations based on pet health data, enhancing treatment precision and owner engagement.
Increasing regulatory scrutiny of therapeutic claims
Regulatory agencies worldwide are intensifying oversight of veterinary diet labeling and health claims, posing compliance risks for manufacturers. Authorities require substantial scientific evidence to support disease-specific assertions, demanding clinical trials and peer-reviewed research that are costly and time-consuming to produce. Unsubstantiated marketing claims can result in product recalls, fines, and reputational damage, while changing regulations across different jurisdictions complicate global product launches. Smaller manufacturers face particular challenges in meeting these evidence requirements, potentially limiting market diversity and innovation. This regulatory environment creates barriers that favor established players with substantial research budgets.
The COVID-19 pandemic significantly accelerated veterinary diet pet food adoption as pet ownership surged and veterinary care patterns shifted. Lockdowns led to unprecedented pet acquisitions, with millions of households adding companion animals, expanding the addressable market. Remote work arrangements increased owner observation of pet health issues, prompting earlier veterinary consultations and dietary interventions. Telemedicine adoption during the pandemic normalized remote prescribing of therapeutic diets, establishing lasting digital care pathways. Supply chain disruptions initially challenged production, but the essential nature of veterinary diets ensured prioritization. The overall effect was sustained market acceleration, with heightened awareness of pet health management persisting post-pandemic.
The Dry Veterinary Diet Food segment is expected to be the largest during the forecast period
The Dry Veterinary Diet Food segment is expected to account for the largest market share during the forecast period, driven by advantages in convenience, cost-effectiveness, and dental health benefits. Kibble-style formulations offer extended shelf life after opening, simpler storage and portion control, and mechanical cleaning action on teeth. Manufacturers can precisely control nutrient density and incorporate heat-stable therapeutic ingredients more easily in dry formats. Pet owners prefer dry food for its affordability compared to wet alternatives and ease of use in automatic feeders. Veterinary compliance is higher for dry diets as they facilitate long-term management of chronic conditions without daily preparation burden.
The Obesity & Weight Management segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Obesity & Weight Management segment is predicted to witness the highest growth rate, reflecting the global epidemic of pet obesity and its associated health complications. Veterinary therapeutic diets targeting weight loss incorporate reduced calorie density, increased fiber, and specific amino acid profiles to preserve lean muscle mass during calorie restriction. Growing awareness that obesity shortens pet lifespan by up to two years is driving proactive veterinary recommendations for weight management interventions. The segment benefits from the high recurrence rate of obesity, requiring ongoing dietary support rather than short-term treatment. Pet owners appreciate the visible results of weight management success, reinforcing adherence.
During the forecast period, the North America region is expected to hold the largest market share, supported by high pet ownership rates, advanced veterinary infrastructure, and strong spending on companion animal health. The region has the highest per capita veterinary expenditure globally, with pet insurance penetration increasing access to therapeutic diets. Major veterinary diet manufacturers are headquartered in North America, ensuring rapid product innovation and widespread distribution through established clinic networks. Consumer awareness of pet chronic disease management is mature, with regular veterinary visits facilitating diagnosis and dietary prescription. The humanization of pets trend is most pronounced in this region, driving premium nutrition adoption.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, fueled by rising disposable incomes, rapid urbanization, and expanding pet ownership among middle-class households. Countries including China, Japan, and South Korea are witnessing significant growth in veterinary services as pet keeping shifts from outdoor working animals to indoor companion status. Western influences on pet care standards, combined with increasing prevalence of obesity and diabetes in pets mirroring human health trends, drive demand for therapeutic nutrition. Government initiatives supporting veterinary infrastructure development and international manufacturers establishing regional production facilities further accelerate market penetration across this emerging region.
Key players in the market
Some of the key players in Veterinary Diet Pet Food Market include Mars Petcare Inc., Nestle Purina PetCare, Colgate-Palmolive Company, Hill's Pet Nutrition, Inc., Royal Canin SAS, The J.M. Smucker Company, General Mills, Inc., Diamond Pet Foods, Wellness Pet Company, Inc., Heristo AG, Tiernahrung Deuerer GmbH, United Petfood Producers NV, Affinity Petcare SA, Freshpet, Inc., and Blue Buffalo Company Ltd.
In February 2026, Royal Canin launched a breed-specific diet for Welsh Corgis, accompanying the release with the "#ShowYourSploot" campaign to celebrate National Welsh Corgi Day.
In February 2026, Freshpet reported that it surpassed $1 billion in annual sales for the first time in 2025. The company announced it is testing "island fridges" in retail stores to increase visibility for its fresh-format therapeutic pet foods.
In June 2025, Hill's completed a major capacity expansion at its Tonganoxie, Kansas, plant to meet the rising global demand for its Prescription Diet canned products, which had previously faced supply chain constraints.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.